4H7-28442-16274
3 vaccinations
13 coded responses
43 check-ins
13 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 021 / MA
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-12
Registered in v-safe
-
2021-04-12
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-12
Survey response — day 0, dose 1MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: Slightly swollen lymph nodes at base of skullMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-14
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea, Dyspnoea exertional — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: Mild shortness of breath while walkingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea — Feeling: Fair · Fatigue or tirednessFree text: Still having some shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea, Pre-existing disease — Feeling: Fair · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Asthma, apparently, was the cause of the shortness of breath. Chest x-ray was clear.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-17
- 2021-04-19
- 2021-04-26
- 2021-05-03
-
2021-05-10
Survey response — day 28, single doseMedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Had a cold over the weekend. I tested negative for COVID.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-17
- 2021-05-25
-
2021-05-25
Call successfulCompleted over the phone
-
2021-07-12
Survey response — 3 months, dose 1MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Caught a coldMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-12
-
2021-11-29
Dose 2 — ModernaCo-administered: Flu
- 2021-11-29
-
2021-11-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-12-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-03
- 2021-12-04
-
2021-12-05
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion, Pre-existing disease — Feeling: GoodFree text: Stuffy nose, probably allergiesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-06
Survey response — day 7, dose 2MedDRA: Nasal congestion, Nasal pruritus, Pre-existing disease — Feeling: GoodFree text: Still have an itchy, stuffy nose, still likely allergiesMedDRA releases: 2024-11 · check-in free text available
- 2021-12-13
- 2021-12-20
-
2021-12-27
Survey response — day 28, dose 2MedDRA: Nasopharyngitis — Feeling: FairFree text: Mild cold symptoms on ThursdayMedDRA releases: 2024-11 · check-in free text available
-
2022-01-05
Survey response — day 35, dose 2MedDRA: Abdominal pain upper — Feeling: GoodFree text: Mild stomach ache yesterdayMedDRA releases: 2024-11 · check-in free text available
-
2022-01-10
Survey response — day 42, dose 2MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Mildly sniffly and congestedMedDRA releases: 2024-11 · check-in free text available
- 2022-02-28
- 2022-05-30
-
2022-06-04
Dose 3 — Moderna
- 2022-06-05
- 2022-06-06
- 2022-06-07
- 2022-06-08
- 2022-06-09
- 2022-06-10
- 2022-06-11
- 2022-06-18
- 2022-06-25
- 2022-07-02
- 2022-07-09
-
2022-07-16
Survey response — day 42, dose 3MedDRA: Fatigue, Headache, Lymphadenopathy, Sinus congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sinus congestion, headache, swollen lymph nodes, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-09-03
Survey response — 3 months, dose 3MedDRA: Upper respiratory tract infection — Feeling: Good · Be unable to do your normal daily activitiesFree text: Upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
- 2022-12-03
- 2023-06-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-29 | Moderna | Flu |
| 3 | 2022-06-04 | Moderna | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): Slightly swollen lymph nodes at base of skull
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Mild shortness of breath while walking
Systemic reaction (other): Still having some shortness of breath
Systemic reaction (other): Asthma, apparently, was the cause of the shortness of breath. Chest x-ray was clear.
Release 8 — day 28, single dose
Symptoms: Had a cold over the weekend. I tested negative for COVID.
Release 9 — 3 months, dose 1
Symptoms: Caught a cold
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Stuffy nose, probably allergies
Release 10 — day 7, dose 2
Systemic reaction (other): Still have an itchy, stuffy nose, still likely allergies
Release 10 — day 28, dose 2
Symptoms: Mild cold symptoms on Thursday
Release 10 — day 35, dose 2
Symptoms: Mild stomach ache yesterday
Release 10 — day 42, dose 2
Symptoms: Mildly sniffly and congested
Release 12 — day 42, dose 3
Symptoms: Sinus congestion, headache, swollen lymph nodes, fatigue
Release 12 — 3 months, dose 3
Symptoms: Upper respiratory infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain upper | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Nasal pruritus | · | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release